Clinical Trials

 

Dr. Joanne Kurtzberg, director of Duke's Pediatric Blood and Marrow Transplantation Program.  Shawn Rocco/Duke Health Geri Dawson, PhD, administers the Early Start Denver Model, which she helped develop, to one of her patients who has autism, at the Duke Child and Family Study Center. (Photo release on file in Duke Photography office.)

The Marcus Center for Cellular Cures (MC3) seeks to develop transformative clinical therapies using cells, tissues, molecules, genes, and biomaterials to treat diseases and injuries that currently lack effective treatments.

Current and potential future clinical trials include treatment for autism and related neurodevelopmental disorders, cerebral palsy, stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, arthritis and joint diseases, and chronic pulmonary diseases.